• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周嗜碱性粒细胞活化:原发性胆汁性胆管炎免疫发病机制中的一个隐藏因素。

Peripheral basophil activation: A hidden player in the immunopathogenesis of primary biliary cholangitis.

作者信息

Han Huan-Qin, Bao Jia-Min, Deng Wei, Guo Wei-Fang, Li Yi-Fan, Zheng Wei-Qiang, Liu Hua-Feng

机构信息

The First Affiliated Hospital, Jinan University, Guangzhou 510630, Guangdong Province, China.

Department of Infectious Diseases and Hepatology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong Province, China.

出版信息

World J Hepatol. 2025 Aug 27;17(8):109685. doi: 10.4254/wjh.v17.i8.109685.

DOI:10.4254/wjh.v17.i8.109685
PMID:40901594
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12400441/
Abstract

BACKGROUND

T helper 17 (Th17) cell infiltration and interleukin (IL)-17 secretion in intrahepatic small bile ducts is a critical driver of immune-mediated injury in primary biliary cholangitis (PBC). IL-6 is an essential upstream activator of Th17 cells. Basophil-derived IL-6 promotes the differentiation of CD4+ T cells and Th1 cells into Th17 cells, thereby regulating their immunological functions.

AIM

To investigate the activation status and cytokine expression of basophils in PBC, elucidating potential mechanisms through which basophils contribute to its pathogenesis.

METHODS

This single-center retrospective case-control study conducted at Guangdong Medical University Affiliated Hospital (China) between September 2019 and August 2024 enrolled 65 consecutive treatment-naïve patients with PBC (PBC group), 65 age- and sex-matched patients with chronic hepatitis B (CHB group), and 65 healthy controls (Normal group). Fourteen participants per group (subgroup) were randomly selected for flow cytometry analysis of basophil proportion, activation markers (CD203c and CD62 L mean fluorescence intensity), IL-6-positive basophils (IL-6+ basophils as a percentage of total basophils), and IL-17-positive T lymphocytes (CD3+CD4+IL-17+ cells) proportion among T cells. Data were analyzed using Kruskal-Wallis and tests as appropriate.

RESULTS

Routine blood tests revealed significantly higher basophil counts and proportions in the PBC group compared to the CHB and Normal groups ( < 0.001 for both comparisons), with no significant differences between the CHB and Normal groups ( = 0.201). Flow cytometry revealed a higher basophil proportion in the PBC subgroup compared to the CHB ( = 0.011) and Normal subgroups ( < 0.001). The mean fluorescence intensity of CD203c on basophil surfaces was elevated in the PBC subgroup compared to the CHB ( = 0.032) and Normal subgroups ( = 0.039). The proportion of IL-6+ basophils was significantly higher in the PBC subgroup than in the CHB ( < 0.01) and Normal subgroups ( < 0.001). Similarly, the Th17 cell proportion was markedly elevated in the PBC compared to the CHB ( < 0.001) and Normal subgroups ( < 0.001).

CONCLUSION

Patients with PBC have increased peripheral basophil counts with enhanced activation. Activated basophils have increased IL-6 expression, which may indirectly induce Th17 cell proliferation and contribute to PBC pathogenesis.

摘要

背景

肝内小胆管中的辅助性T细胞17(Th17)细胞浸润和白细胞介素(IL)-17分泌是原发性胆汁性胆管炎(PBC)免疫介导损伤的关键驱动因素。IL-6是Th17细胞必不可少的上游激活因子。嗜碱性粒细胞衍生的IL-6促进CD4+T细胞和Th1细胞分化为Th17细胞,从而调节其免疫功能。

目的

研究PBC中嗜碱性粒细胞的激活状态和细胞因子表达,阐明嗜碱性粒细胞参与其发病机制的潜在机制。

方法

本单中心回顾性病例对照研究于2019年9月至2024年8月在中国广东医科大学附属医院进行,连续纳入65例未经治疗的PBC患者(PBC组)、65例年龄和性别匹配的慢性乙型肝炎患者(CHB组)和65例健康对照者(正常组)。每组(亚组)随机选取14名参与者,进行流式细胞术分析嗜碱性粒细胞比例、激活标志物(CD203c和CD62L平均荧光强度)、IL-6阳性嗜碱性粒细胞(IL-6+嗜碱性粒细胞占嗜碱性粒细胞总数的百分比)以及T细胞中IL-17阳性T淋巴细胞(CD3+CD4+IL-17+细胞)比例。数据采用Kruskal-Wallis检验和适当的检验进行分析。

结果

常规血液检查显示,与CHB组和正常组相比,PBC组嗜碱性粒细胞计数和比例显著更高(两组比较均P<0.001),CHB组和正常组之间无显著差异(P=0.201)。流式细胞术显示,与CHB亚组(P=0.011)和正常亚组(P<0.001)相比,PBC亚组嗜碱性粒细胞比例更高。与CHB亚组(P=0.032)和正常亚组(P=0.039)相比,PBC亚组嗜碱性粒细胞表面CD203c的平均荧光强度升高。PBC亚组IL-6+嗜碱性粒细胞比例显著高于CHB亚组(P<0.01)和正常亚组(P<0.001)。同样,与CHB亚组(P<0.001)和正常亚组(P<0.001)相比,PBC组Th17细胞比例显著升高。

结论

PBC患者外周嗜碱性粒细胞计数增加且激活增强。激活的嗜碱性粒细胞IL-6表达增加,这可能间接诱导Th17细胞增殖并参与PBC发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/0fa8e24437b9/wjh-17-8-109685-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/ed4734439a2b/wjh-17-8-109685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/1b05d23ef9e2/wjh-17-8-109685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/07cd02c16f6e/wjh-17-8-109685-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/019beb6b0b33/wjh-17-8-109685-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/11db7b97be82/wjh-17-8-109685-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/0fa8e24437b9/wjh-17-8-109685-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/ed4734439a2b/wjh-17-8-109685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/1b05d23ef9e2/wjh-17-8-109685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/07cd02c16f6e/wjh-17-8-109685-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/019beb6b0b33/wjh-17-8-109685-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/11db7b97be82/wjh-17-8-109685-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e6b/12400441/0fa8e24437b9/wjh-17-8-109685-g006.jpg

相似文献

1
Peripheral basophil activation: A hidden player in the immunopathogenesis of primary biliary cholangitis.外周嗜碱性粒细胞活化:原发性胆汁性胆管炎免疫发病机制中的一个隐藏因素。
World J Hepatol. 2025 Aug 27;17(8):109685. doi: 10.4254/wjh.v17.i8.109685.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
4
B cells drive CCR5CD4 tissue-resident memory T cell cytotoxicity via IL-15Rα-IL-15 signaling in primary biliary cholangitis.在原发性胆汁性胆管炎中,B细胞通过IL-15Rα-IL-15信号传导驱动CCR5CD4组织驻留记忆T细胞的细胞毒性。
J Hepatol. 2025 Jul 17. doi: 10.1016/j.jhep.2025.06.037.
5
[Effects of PEG-IFN-α treatment on the expression of CD161 and PD-1 in CD8 T cells of patients with chronic hepatitis B].[聚乙二醇干扰素-α治疗对慢性乙型肝炎患者CD8⁺ T细胞中CD161和PD-1表达的影响]
Zhonghua Gan Zang Bing Za Zhi. 2025 Jun 20;33(6):570-576. doi: 10.3760/cma.j.cn501113-20240921-00501.
6
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.原发性胆汁性胆管炎的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011648. doi: 10.1002/14651858.CD011648.pub2.
7
The relationship between hematological parameters such as eosinophil-basophil levels, eosinophil-to-basophil ratio, monocyte-to-basophil ratio, and the coronary slow flow phenomenon.嗜酸性粒细胞-嗜碱性粒细胞水平、嗜酸性粒细胞与嗜碱性粒细胞比值、单核细胞与嗜碱性粒细胞比值等血液学参数与冠状动脉慢血流现象之间的关系。
Medicine (Baltimore). 2025 Aug 8;104(32):e43819. doi: 10.1097/MD.0000000000043819.
8
T-bet expressing Tr1 cells driven by dietary signals dominate the small intestinal immune landscape.由饮食信号驱动的表达T-bet的Tr1细胞主导小肠免疫格局。
bioRxiv. 2025 Jul 4:2025.06.30.662190. doi: 10.1101/2025.06.30.662190.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Endothelial cells expressing CPE and vWF are involved in the Immunopathogenesis of primary biliary cholangitis.表达羧肽酶E和血管性血友病因子的内皮细胞参与原发性胆汁性胆管炎的免疫发病机制。
Sci Rep. 2025 Jul 2;15(1):22640. doi: 10.1038/s41598-025-07311-z.

本文引用的文献

1
Obeticholic Acid vs Fibrates as Second-Line Therapy for Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.奥贝胆酸与贝特类药物作为原发性胆汁性胆管炎二线治疗的系统评价和荟萃分析
Dig Dis Sci. 2025 Apr 19. doi: 10.1007/s10620-025-09044-5.
2
IgE-Mediated Activation of Mast Cells and Basophils in Health and Disease.健康与疾病中IgE介导的肥大细胞和嗜碱性粒细胞活化
Immunol Rev. 2025 May;331(1):e70024. doi: 10.1111/imr.70024.
3
Primary biliary cholangitis: a summary of pathogenesis and therapies.原发性胆汁性胆管炎:发病机制与治疗概述
Ann Gastroenterol. 2025 Mar-Apr;38(2):121-132. doi: 10.20524/aog.2025.0953. Epub 2025 Feb 28.
4
Atg5 deficiency in basophils improves metabolism in lupus mice by regulating gut microbiota dysbiosis.嗜碱性粒细胞中Atg5的缺失通过调节肠道微生物群失调改善狼疮小鼠的代谢。
Cell Commun Signal. 2025 Jan 22;23(1):40. doi: 10.1186/s12964-025-02041-1.
5
The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects.原发性胆汁性胆管炎的免疫格局:机制与治疗前景。
Hepatology. 2025 Jan 3. doi: 10.1097/HEP.0000000000001225.
6
Primary biliary cholangitis.原发性胆汁性胆管炎。
Lancet. 2024 Sep 14;404(10457):1053-1066. doi: 10.1016/S0140-6736(24)01303-5. Epub 2024 Aug 28.
7
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022).《慢性乙型肝炎防治指南(2022年版)》
J Clin Transl Hepatol. 2023 Nov 28;11(6):1425-1442. doi: 10.14218/JCTH.2023.00320. Epub 2023 Aug 15.
8
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.亚太肝脏研究学会临床实践指南:原发性胆汁性胆管炎患者的诊断与管理
Hepatol Int. 2022 Feb;16(1):1-23. doi: 10.1007/s12072-021-10276-6. Epub 2022 Feb 4.
9
Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases.原发性胆汁性胆管炎:美国肝病研究协会2021年实践指南更新
Hepatology. 2022 Apr;75(4):1012-1013. doi: 10.1002/hep.32117. Epub 2021 Dec 20.
10
Primary biliary cholangitis.原发性胆汁性胆管炎。
Lancet. 2020 Dec 12;396(10266):1915-1926. doi: 10.1016/S0140-6736(20)31607-X.